Skip to main content
. Author manuscript; available in PMC: 2015 May 8.
Published in final edited form as: Expert Rev Vaccines. 2009 Sep;8(9):1251–1276. doi: 10.1586/erv.09.77

Table 13.

Vaccines against Johne’s disease.

Vaccine Vector Species Dosage Vaccination
ages
Immunity Ref.
Mycopar® (Fort
Dodge, KS,
USA)
Whole-cell bacterin
containing inactivated
Mycobacterium
paratuberculosis bacteria
suspended in oil
Cattle,
sheep
Cattle:
0.5 ml sc.
Sheep:
1 ml sc.
Calves: less than
35 days
Sheep: 3 months
Cattle: ~90% effective in
eliminating clinical disease
Sheep: specific humoral and
cellular responses elicited
[106,107]
Silirum® (Pfizer,
NY, USA)
Killed bacteria in mineral
oil adjuvant
Cattle,
deer
One dose sc.
for cattle and
deer
Calves: 14 days
Deer: 5 months
Cattle: no antibodies. Reduced
colonization of tissues by
pathogen
Deer: reduced severity of disease
[108,109]
DNA vaccine
(Kathaperumal
et al. 2008)
Four rAgs (85A, 85B, 85C
and superoxide dismutase)
with two adjuvants
(monophosphoryl lipid A
and bovine IL-12)
Cattle 100 µg of
each antigen
and 100 µg
of IL-12 im.
5–10 days Antibodies within 3 weeks;
significant IFN-γ production
within 11 weeks
Significant increases in CD4+ and
CD8+ T cells against all four rAgs;
rAg-specific expression of IL-2,
IL-12 and TNF-α. 4/8 animals did
not show bacteria in tissue
[104]
DNA vaccine
(Sechi et al.
2005)
Three rAgs (Mycobacterium
avium 85A, BCG 85A
and 65K)
Sheep Three doses
of 1 mg of
each antigen
im. 20 days
apart
5 months Increased IFN-γ and IL-10
expression, increased CD4+ T cells
Absence of lesions and bacteria
in tissues
[105]

Im.: Intramuscular; rAg: Recombinant antigen; sc.: Subcutaneous.